Low-amplitude GPi stimulation inhibited the thalamic neurons ... It is likely that the modulation comes about through the local effects of the DBS electrode on the neural activity in the DBS ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Carnegie Mellon researchers developed "DeepFocus," a new method for brain stimulation that combines transnasal and transcranial electrical stimulation for minimally invasive targeting of deep brain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback